Overview of external reference pricing systems in Europe
نویسندگان
چکیده
منابع مشابه
Selecting reference countries in external reference based pricing: The case study of Iran
Most countries are using some kinds of pharmaceutical policies, like external reference-based pricing, to control the costs of medicines. This policy could be implemented in different ways and there is no systematic method for selecting reference countries. In this study, we tried to identify and classify the factors affecting the selection of reference countries in Iran. Delphi method was empl...
متن کاملReference pricing systems in Europe: characteristics and consequences
Submitted: 16 May 2012; Revised: 8 August 2012; Accepted: 15 August 2012; Published online first: 17 August 2012 Introduction A reference pricing system is a system that establishes a reimbursement level or reference price for a group of interchangeable medicines. If a medicine is priced above the reference price, the patient pays the difference between the price of the medicine and the referen...
متن کاملReview of Pricing And Reimbursement Systems in South-Eastern Europe.
Reimbursement lists: A. Generics/other less expensive drugs with good cost-effectiveness: 90% reimbursement B. Essential but more expensive drugs: 50% reimbursement C. Specified conditions, prescribed by specialists: C1: Ambulatory care medicines for severe/ chronic diseases C2: Hospital only C3: A+B plus additional OTC products limited to persons <18 years old, students, pregnant women and you...
متن کاملReference pricing of pharmaceuticals.
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry costs. The other brand-name drug has already lost its patent and faces competition from a third firm offer...
متن کاملA review of genericmedicine pricing in Europe
Intr oduction Generic medicines are a key instrument for governments to sustain their healthcare systems and control pharmaceutical expenditures. This contribution of generic medicines to the sustainability of European healthcare systems has been recognised by the High Level Pharmaceutical Forums, ‘Generic medicines provide an opportunity to obtain similar treatments at lower costs for patients...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Market Access & Health Policy
سال: 2015
ISSN: 2001-6689
DOI: 10.3402/jmahp.v3.27675